Jaime Bartushak
2020
In 2020, Jaime Bartushak earned a total compensation of $514.5K as Chief Financial Officer at Citius Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $74,513 |
| Salary | $290,000 |
| Total | $514,513 |
Bartushak received $290K in salary, accounting for 56% of the total pay in 2020.
Bartushak also received $150K in non-equity incentive plan and $74.5K in option awards.
Rankings
In 2020, Jaime Bartushak's compensation ranked 10,952nd out of 13,090 executives tracked by ExecPay. In other words, Bartushak earned more than 16.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,952 out of 13,090 | 16th |
Division Manufacturing | 4,678 out of 5,620 | 17th |
Major group Chemicals And Allied Products | 1,942 out of 2,253 | 14th |
Industry group Drugs | 1,699 out of 1,953 | 13th |
Industry Pharmaceutical Preparations | 1,256 out of 1,458 | 14th |
Source: SEC filing on December 21, 2020.
Bartushak's colleagues
We found three more compensation records of executives who worked with Jaime Bartushak at Citius Pharmaceuticals in 2020.
News
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018